About Kaida Biopharma
Kaida Biopharma is a private company based in Fort Lauderdale, Florida, incorporated in 2022 in Delaware. It has reported $1,604,527 raised in two offerings on Form D since June 2023.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 24, 2023 | Jan 21, 2026amended Sep 1, 2026 | $1,600,507of $4.1M target | 44 | $36,375 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Jun 1, 2023 | Jun 14, 2023 | $4,020fully sold | 47 | $86 | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $1,604,527 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Kaida Biopharma's Form D filed Sep 1, 2026.
Earlier filings also listed Stephen Dunn (director, last listed Jun 2023).